New Insight for Enhanced Topical Targeting of Caffeine for Effective Cellulite Treatment: In Vitro Characterization, Permeation Studies, and Histological Evaluation in Rats.
Abstract
Cellulite (CLT) is one of the commonly known lipodystrophy syndromes affecting post-adolescent women worldwide. It is topographically characterized by an orange-peel, dimpled skin appearance hence, it is an unacceptable cosmetic problem. CLT can be modulated by surgical procedures such as; liposuction and mesotherapy. But, these options are invasive, expensive and risky. For these reasons, topical CLT treatments are more preferred. Caffeine (CA), is a natural alkaloid that is well-known for its prominent anti-cellulite effects. However, its hydrophilicity hinders its cutaneous permeation. Therefore, in the present study CA was loaded into solid lipid nanoparticles (SLNs) by high shear homogenization/ultrasonication. CA-SLNs were prepared using Compritol® 888 ATO and stearic acid as solid lipids, and span 60 and brij™35, as lipid dispersion stabilizing agents. Formulation variables were adjusted to obtain entrapment efficiency (EE > 75%), particle size (PS < 350 nm), zeta potential (ZP < -25 mV) and polydispersity index (PDI < 0.5). CA-SLN-4 was selected and showed maximized EE (92.03 ± 0.16%), minimized PS (232.7 ± 1.90 nm), and optimum ZP (-25.15 ± 0.65 mV) and PDI values (0.24 ± 0.02). CA-SLN-4 showed superior CA release (99.44 ± 0.36%) compared to the rest CA-SLNs at 1 h. TEM analysis showed spherical, nanosized CA-SLN-4 vesicles. Con-LSM analysis showed successful CA-SLN-4 permeation transepidermally and via shunt diffusion. CA-SLN-4 incorporated into Noveon AA-1® hydrogel (CA-SLN-Ngel) showed accepted physical/rheological properties, and in vitro release profile. Histological studies showed that CA-SLN-Ngel significantly reduced mean subcutaneous fat tissue (SFT) thickness with 4.66 fold (p = 0.035) and 4.16 fold (p = 0.0001) compared to CA-gel, at 7th and 21st days, respectively. Also, significant mean SFT thickness reduction was observed compared to untreated group with 4.83 fold (p = 0.0005) and 3.83 fold (p = 0.0043), at 7th and 21st days, respectively. This study opened new avenue for CA skin delivery via advocating the importance of skin appendages. Hence, CA-SLN-Ngel could be a promising nanocosmeceutical gel for effective CLT treatment.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | liposuction
|
지방흡입 | dict | 1 | |
| 해부 | skin
|
scispacy | 1 | ||
| 해부 | vesicles
|
scispacy | 1 | ||
| 해부 | subcutaneous fat tissue
|
scispacy | 1 | ||
| 해부 | subcutaneous
|
피하조직 | dict | 1 | |
| 약물 | Caffeine
|
C0006644
caffeine
|
scispacy | 1 | |
| 약물 | CLT
→ Cellulite
|
C0424624
Cellulite
|
scispacy | 1 | |
| 약물 | Compritol
|
scispacy | 1 | ||
| 약물 | ATO
|
scispacy | 1 | ||
| 약물 | stearic acid
|
C0038229
stearic acid
|
scispacy | 1 | |
| 약물 | Noveon AA-1
|
scispacy | 1 | ||
| 약물 | brij
|
scispacy | 1 | ||
| 약물 | lipid
|
scispacy | 1 | ||
| 질환 | Cellulite
|
C0424624
Cellulite
|
scispacy | 1 | |
| 질환 | lipodystrophy syndromes affecting post-adolescent women
|
scispacy | 1 | ||
| 질환 | orange-peel
|
scispacy | 1 | ||
| 질환 | polydispersity
|
scispacy | 1 | ||
| 질환 | solid lipid nanoparticles
|
scispacy | 1 | ||
| 질환 | SLNs
→ solid lipid nanoparticles
|
scispacy | 1 | ||
| 질환 | solid lipids
|
scispacy | 1 | ||
| 질환 | SFT
→ subcutaneous fat tissue
|
scispacy | 1 | ||
| 기타 | Rats
|
scispacy | 1 | ||
| 기타 | women
|
scispacy | 1 | ||
| 기타 | Compritol® 888
|
scispacy | 1 | ||
| 기타 | PDI
|
scispacy | 1 | ||
| 기타 | skin appendages
|
scispacy | 1 |
MeSH Terms
Animals; Caffeine; Cellulite; Rats; Nanoparticles; Particle Size; Skin Absorption; Administration, Cutaneous; Skin; Permeability; Lipids; Chemistry, Pharmaceutical; Drug Delivery Systems; Rats, Wistar; Administration, Topical; Drug Carriers; Female; Liposomes
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Implant-based versus autologous mastopexy after massive weight loss: Complications and patient satisfaction.
- Hyperhidrosis: Prevalence, Diagnosis, and Stepwise Treatment.
- Application of the SCIA-Pure Skin Perforator Flap in Bilateral Upper Eyelid Reconstruction: A Case Report and Review of the Literature.
- Venous thromboembolism prophylaxis regimen for patients undergoing deep inferior epigastric perforator flap breast reconstruction.
- Immediate one-stage subcutaneous breast reconstruction without ADM: A single-center 6-year experience.